Trending News

A woman scratching her skin
#Antibodies #Atopic dermatitis #Dermatology #Immunotherapy #Monoclonal antibodies

New dermatitis treatment shows promising long-term results

A novel, patient-tailored monoclonal antibody therapy has shown promise in treating moderate to severe atopic dermatitis.  Patients who participated in a clinical trial of rocatinlimab showed positive results while taking the drug and up to 20 weeks after stopping therapy, Mount Sinai researchers have… Read More

#News #Trending News

Patient using a mammography machine
#AstraZeneca #Breast cancer #Cancer research #Phase III trial #Precision medicine #The Institute of Cancer Research

Targeted breast cancer drug extends lives of patients in Phase III trial

A new type of targeted medicine has shown ‘remarkable’ benefits for patients with advanced breast cancer in a major Phase III clinical trial.  The drug capivasertib combined with hormone therapy doubled the time it took for cancer to progress in people with advanced forms of the most… Read More

#Cancer Research #News #Trending News

HIV vaccine
#Antibodies #HIV #mRNA-based vaccines #Phase I trial

Encouraging trial findings renew hope for HIV vaccine

While scientists have struggled in the past to create an effective vaccine against HIV, a novel vaccine design strategy shows new promise, according to data from a first-in-human clinical trial.  In a paper published in Science, the researchers reveal critical new insights… Read More

#News #Trending News

CAR-T therapy
#Autoimmune disease #Cancer #CAR-T #Immunotherapy #Mouse models

CAR-T therapy successfully used to treat autoimmune disease

CAR-T therapy can be used to eliminate unwanted cells that cause autoimmunity, according to the results of a new study in mice with an autoimmune disease similar to multiple sclerosis (MS).  CAR-T, which uses genetically altered immune cells to destroy cancer cells, has revolutionised treatment of some… Read More

#News #Trending News

Hemp plants being used in scientific research
#Chronic pain #MHRA #THC #UK

UK approval for CBD pain treatment

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a CBD/THC combination treatment under its Named Patient programme and other compassionate areas. Medlab’s NanaBis, to be used under NanaDol, a botanical version of NanaBis, has previously shown encouraging Phase I/II data for the treatment of cancer-induced bone pain… Read More

#News #Regulatory #Trending News

Psychiatrist with patient
#Major depressive disorder #Neuroscience #Phase I trial

Injectable drug could offer new option for depressive disorders

The first subject has been dosed in a Phase I biomarker study of apimostinel, a rapid-acting N-methyl-D-aspartate receptor (NMDAR) modulator for major depressive disorders (MDD).  The injectable treatment was developed by clinical-stage biotechnology company Gate Neurosciences for acute depressive disorders… Read More

#News #Trending News

MRI of the brain
#epilepsy #Mouse models #Neuroinflammation #Neuroscience

Neuroscientists discover new drug candidate for treating epilepsy

Neuroscientists have identified and developed a new drug candidate that has the potential to effectively treat temporal lobe epilepsy (TLE) by suppressing neuroinflammation.  Although symptomatic medications are available, one-third of TLE patients remain unresponsive to current treatment, so new drug targets are critically needed. Most of these… Read More

#News #Trending News

Antibiotics
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials

World Antimicrobial Awareness Week: Antibiotics in the news 

For World Antimicrobial Awareness Week (18-24 November), DDW’s Diana Spencer provides an overview of the latest news in antimicrobial resistance and drug discovery.  1. New class of antibiotics for TB A first-in-class investigational antitubercular agent has shown early bactericidal activity with a low, once-daily oral dose after 14 days of… Read More

#Exclusive Content #News #Trending News

Pseudomonas aeruginosa
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials #Gut microbiome

How antibiotic resistant gut bacteria cause lung infections

An Oxford University study has provided the first evidence that antibiotic resistant bacteria can travel from the gut to the lung, increasing the risk of deadly infections.  The findings coincide with World Antimicrobial Awareness Week and shed light on how antimicrobial resistance (AMR) arises and persists.  … Read More

#News #Trending News

World AMR Awareness Week logo
#ABPI #Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Association of the British Pharmaceutical Industry #UK

New antibiotics the only way to combat AMR, says ABPI 

Developing new antibiotics is essential to winning the fight against resistant infections, the Association of the British Pharmaceutical Industry (ABPI) has said.  The comments come ahead of World Antimicrobial Awareness Week (18-24 November), which aims to improve the awareness and understanding of antimicrobial resistance (AMR).   The… Read More

#News #Trending News

Patient taking antibiotics
#Antibiotics #GSK #Phase II trial #TB #Tuberculosis

New class of antibiotics could help address the TB epidemic 

A first-in-class investigational antitubercular agent has shown early bactericidal activity with a low, once-daily oral dose after 14 days of treatment.  The Phase IIa study evaluated GSK’s GSK3036656 in participants with drug-susceptible pulmonary tuberculosis. The company hopes GSK3036656 could be a component of simpler treatment regimens in… Read More

#News #Trending News

World Diabetes Day
#Diabetes #Drug discovery #Type 1 diabetes #Type 2 diabetes #World Diabetes Day

World Diabetes Day: Five drug discovery developments 

For World Diabetes Day, DDW’s Diana Spencer provides an overview of the latest innovations in the treatment of the disease. Here are 2022’s five most significant discoveries (in no particular order):  1. Human beta cell model Earlier this year, Human Cell Design, a biotechnology company focused on generating translational human… Read More

#Exclusive Content #News #Trending News